Clinical Research Directory
Browse clinical research sites, groups, and studies.
4 clinical studies listed.
Filters:
Tundra lists 4 Mastalgia clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.
This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.
NCT07257770
Local Treatment of Breast Pain Based on the Daily Use of a Topical Gel
The trial aims to investigate the effect of a topical application of a medical device based on inositol in recovering breast pain
Gender: FEMALE
Ages: 18 Years - 70 Years
Updated: 2026-02-13
NCT06966245
External Mastalgia-oil Versus Placebo in Premenopausal Women With Severe Mastalgia
This is a single-center, double-blind, randomized clinical trial to explore the efficacy and safety of external mastalgia-oil versus placebo in premenopausal women with severe mastalgia.
Gender: FEMALE
Ages: 18 Years - 60 Years
Updated: 2026-02-02
NCT06404775
External Mastalgia-oil Versus Oral Tamoxifen in Premenopausal Women with Severe Mastalgia
This is a single-center, double-blind, double-simulated, positive-controlled, randomized clinical trial to explore the efficacy and safety of external mastalgia-oil versus oral tamoxifen in premenopausal women with severe mastalgia.
Gender: FEMALE
Ages: 18 Years - 60 Years
Updated: 2024-11-29
1 state
NCT05408377
Effectiveness of Acupuncture for Cyclical Mastalgia (CM)
This study is a multi-center 2-arm randomized controlled trial. According to the ratio of 1:1 and block randomization, a total of 108 eligible CM patients will be randomly allocated to either MA(n=54) or SA(n=54). All patients will undergo treatment two weeks before menstruation and treatment will be stopped at the onset of menstruation. Three times a week, six times a menstrual cycle, 3consecutive menstrual cycles for a total of 18 sessions after baseline. The primary outcome will be the change in the average daily breast pain VAS(VAS-BP) scores during the first 2 weeks of menstruation from baseline at weeks 4,8,12. Additionally, VAS-BP scores at weeks 24 and 36 will also be assessed. Secondary outcomes will include the number of nominal days of breast pain (NDBP) 2 weeks before menstruation, WHOQOL-BREF scores, patient global assessment, breast glandular section thickness, and breast duct width three days before menstruation from baseline at weeks 12. This study will evaluate the effectiveness and safety of acupuncture to alleviate cyclic breast pain and to further explore the possible mechanisms underlying the effect.
Gender: FEMALE
Ages: 18 Years - 45 Years
Updated: 2024-04-09
1 state